Company Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis.
The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata.
The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019.
Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
| Country | United States |
| IPO Date | Jan 31, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 296 |
| CEO | Todd Franklin Watanabe M.A. |
Contact Details
Address: 3027 Townsgate Road Westlake Village, California United States | |
| Website | https://www.arcutis.com |
Stock Details
| Ticker Symbol | ARQT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001787306 |
| CUSIP Number | 03969K108 |
| ISIN Number | US03969K1088 |
| Employer ID | 81-2974255 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Todd Franklin Watanabe M.A. | President, Chief Executive Officer & Director |
| David J. Topper | Senior Vice President & Chief Financial Officer |
| Amanda Sheldon | Head of Corporate Communications |
| Courtney Barton | Vice President and Chief Compliance Officer & Privacy Officer |
| Dr. Bhaskar Chaudhuri Ph.D. | Co-Founder & Independent Director |
| Dr. Patrick E. Burnett M.D., Ph.D. | Executive Vice President & Chief Medical Officer |
| Kent Taylor | Senior Vice President of Sales |
| L. Todd Edwards | Executive Vice President & Chief Commercial Officer |
| Masaru Matsuda Esq., J.D. | Senior Vice President, General Counsel & Corporate Secretary |
| Rajvir Madan | Chief Digital & Technology Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 13, 2025 | 8-K | Current Report |
| Jan 06, 2025 | 4 | Filing |
| Dec 31, 2024 | 4 | Filing |
| Dec 23, 2024 | 4 | Filing |
| Dec 03, 2024 | 4 | Filing |
| Dec 03, 2024 | 4 | Filing |
| Dec 03, 2024 | 4 | Filing |
| Dec 03, 2024 | 4 | Filing |
| Nov 26, 2024 | 4 | Filing |
| Nov 19, 2024 | 4 | Filing |